These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 7533361

  • 21. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy.
    Nakamura Y, Takeuchi H, Okuyama K, Akashi T, Jojima Y, Konno O, Akashi I, Hama K, Iwahori T, Ashizawa T, Hirano T, Oka K, Matsuno N, Nagao T.
    Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445
    [Abstract] [Full Text] [Related]

  • 22. Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus.
    Therapondos G, Flapan AD, Dollinger MM, Garden OJ, Plevris JN, Hayes PC.
    Liver Transpl; 2002 Aug; 8(8):690-700. PubMed ID: 12149762
    [Abstract] [Full Text] [Related]

  • 23. Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection.
    Meiser BM, Uberfuhr P, Fuchs A, Schmidt D, Pfeiffer M, Paulus D, Schulze C, Wildhirt S, Scheidt WV, Angermann C, Klauss V, Martin S, Reichenspurner H, Kreuzer E, Reichart B.
    J Heart Lung Transplant; 1998 Aug; 17(8):782-8. PubMed ID: 9730427
    [Abstract] [Full Text] [Related]

  • 24. Successful pregnancy in a patient after liver transplantation maintained on FK 506.
    Winkler ME, Niesert S, Ringe B, Pichlmayr R.
    Transplantation; 1993 Dec; 56(6):1589-90. PubMed ID: 7506460
    [No Abstract] [Full Text] [Related]

  • 25. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 26. Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients.
    Winkler M, Jost U, Ringe B, Gubernatis G, Wonigeit K, Pichlmayr R.
    Transplant Proc; 1991 Dec; 23(6):3153-5. PubMed ID: 1721389
    [No Abstract] [Full Text] [Related]

  • 27. FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man.
    Söderdahl G, Groth CG, Angelin B, Duraj F, Einarsson K, Ericzon BG.
    Transplant Proc; 1995 Feb; 27(1):1125. PubMed ID: 7533362
    [No Abstract] [Full Text] [Related]

  • 28. Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients.
    Loss M, Winkler M, Schneider A, Brinkmann C, Manns M, Ringe B, Pichlmayr R.
    Transplant Proc; 1995 Feb; 27(1):1136-9. PubMed ID: 7533365
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring.
    Winkler M, Wonigeit K, Undre N, Ringe B, Oldhafer K, Christians U, Pichlmayr R.
    Transplant Proc; 1995 Feb; 27(1):822-5. PubMed ID: 7533433
    [No Abstract] [Full Text] [Related]

  • 30. Administration of tacrolimus in 50 liver transplantation patients.
    Ye QF, Ruzig MA, Gong NQ.
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):492-4. PubMed ID: 14607673
    [Abstract] [Full Text] [Related]

  • 31. Tacrolimus (FK506): the pros and cons of its use as an immunosuppressant in pediatric liver transplantation.
    Cox KL, Freese DK.
    Clin Invest Med; 1996 Oct; 19(5):389-92. PubMed ID: 8889279
    [Abstract] [Full Text] [Related]

  • 32. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
    Woodle ES, Perdrizet GA, So S, Jendrisak MD, White HM, Marsh JW.
    Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
    [No Abstract] [Full Text] [Related]

  • 33. Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK 506.
    Lopez OL, Martinez AJ, Torre-Cisneros J.
    Transplant Proc; 1991 Dec; 23(6):3181-2. PubMed ID: 1721400
    [No Abstract] [Full Text] [Related]

  • 34. Monitoring FK 506 concentrations in plasma and whole blood.
    Jusko WJ, D'Ambrosio R.
    Transplant Proc; 1991 Dec; 23(6):2732-5. PubMed ID: 1721260
    [Abstract] [Full Text] [Related]

  • 35. Management of living donor liver transplant patients using twice-daily 4-hour intravenous cyclosporine therapy.
    Sato K, Iwane T, Sekiguchi S, Nakamura A, Akamatsu Y, Kawagishi N, Miyagi S, Takeda I, Sato A, Fujimori K, Satomi S.
    Transplant Proc; 2009 Dec; 41(1):229-32. PubMed ID: 19249521
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations.
    Yasuhara M, Hashida T, Toraguchi M, Hashimoto Y, Kimura M, Inui K, Hori R, Inomata Y, Tanaka K, Yamaoka Y.
    Transplant Proc; 1995 Feb; 27(1):1108-10. PubMed ID: 7533356
    [No Abstract] [Full Text] [Related]

  • 37. Neurotoxicity of FK 506 in liver transplant recipients.
    Frank B, Perdrizet GA, White HM, Marsh JW, Lemann W, Woodle ES.
    Transplant Proc; 1993 Apr; 25(2):1887-8. PubMed ID: 7682355
    [No Abstract] [Full Text] [Related]

  • 38. Oral administration of FK 506 in a swine model of liver-small bowel allotransplantation.
    Reggiani P, Gatti S, Rossi G, Orsenigo R, Maggi U, Leoni L, Ceccherelli F, Colledan M, Gridelli B, Piazzini-Albani A, Galmarini M, Andreani P, Bardella MT, Langer M, Doglia M, Fassati LR, Galmarini D.
    Transplant Proc; 1996 Oct; 28(5):2587-8. PubMed ID: 8907965
    [No Abstract] [Full Text] [Related]

  • 39. Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up.
    Jonas S, Neuhaus R, Junge G, Klupp J, Theruvat T, Langrehr JM, Settmacher U, Neuhaus P.
    Int Immunopharmacol; 2005 Jan; 5(1):125-8. PubMed ID: 15589470
    [Abstract] [Full Text] [Related]

  • 40. FK 506 rescue therapy: early conversion improves efficacy.
    Woodle ES, Perdrizet GA, So S, Jendrisak MD, White HM, Marsh JW.
    Transplant Proc; 1993 Apr; 25(2):1990-1. PubMed ID: 7682359
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.